Mehta Vikram, Harward Stephen C, Sankey Eric W, Nayar Gautam, Codd Patrick J
Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA.
J Clin Neurosci. 2018 Apr;50:7-15. doi: 10.1016/j.jocn.2018.01.050. Epub 2018 Feb 7.
Chronic subdural hematomas are encapsulated blood collections within the dural border cells with characteristic outer "neomembranes". Affected patients are more often male and typically above the age of 70. Imaging shows crescentic layering of fluid in the subdural space on a non-contrast computed tomography (CT) scan, best appreciated on sagittal or coronal reformats. Initial medical management involves reversing anticoagulant/antiplatelet therapies, and often initiation of anti-epileptic drugs (AEDs). Operative interventions, such as twist-drill craniostomy (TDC), burr-hole craniostomy (BHC), and craniotomy are indicated if imaging implies compression (maximum fluid collection thickness >1 cm) or the patient is symptomatic. The effectiveness of various surgical techniques remains poorly characterized, with sparse level 1 evidence, variable outcome measures, and various surgical techniques. Postoperatively, subdural drains can decrease recurrence and sequential compression devices can decrease embolic complications, while measures such as early mobilization and re-initiation of anticoagulation need further study. Non-operative management, including steroid therapy, etizolam, tranexamic acid, and angiotensin converting enzyme inhibitors (ACEI) also remain poorly studied. Recurrent hemorrhages are a major complication affecting around 10-20% of patients, and therefore close follow-up is essential.
慢性硬膜下血肿是硬脑膜边界细胞内的包裹性血肿,具有特征性的外层“新膜”。受影响的患者男性更为常见,通常年龄在70岁以上。影像学检查显示,在非增强计算机断层扫描(CT)上,硬膜下间隙有新月形液体分层,在矢状面或冠状面重建图像上显示最佳。初始药物治疗包括停用抗凝/抗血小板治疗,通常还需开始使用抗癫痫药物(AEDs)。如果影像学检查提示有压迫(最大液体聚集厚度>1厘米)或患者有症状,则需进行手术干预,如锥孔钻颅脑造口术(TDC)、钻孔颅脑造口术(BHC)和开颅手术。各种手术技术的有效性仍未得到充分描述,一级证据稀少,结果测量指标各异,手术技术也多种多样。术后,硬膜下引流可降低复发率,序贯压迫装置可减少栓塞并发症,而早期活动和重新开始抗凝等措施仍需进一步研究。非手术治疗,包括类固醇治疗、依替唑仑、氨甲环酸和血管紧张素转换酶抑制剂(ACEI)的研究也较少。复发性出血是一种主要并发症,约10-20%的患者会受到影响,因此密切随访至关重要。